US Stock MarketDetailed Quotes

SUPN Supernus Pharmaceuticals

Watchlist
  • 28.770
  • -0.330-1.13%
Close May 20 16:00 ET
1.58BMarket Cap-107350P/E (TTM)

Supernus Pharmaceuticals Key Stats

Supernus Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 8, 2024

Revenue(YoY)

143.64M

-6.58%
EPS(YoY)

<0.01

-99.23%

Buy

May 15, 2024

Supernus Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 155.928M--
--2024/Q2-- / 149.469M--
May 8, 20242024/Q1143.644M / 145.832M--
Feb 27, 20242023/Q4164.314M / 155.031M--
Nov 8, 20232023/Q3153.880M / 143.387M--
Aug 8, 20232023/Q2135.563M / 143.658M--
May 9, 20232023/Q1153.764M / 139.023M--
--2022/Q4167.328M / 180.375M--
Nov 8, 20222022/Q3177.353M / 172.476M--
Aug 4, 20222022/Q2170.051M / 164.229M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 155.928M--
--2024/Q2-- / 149.469M--
May 8, 20242024/Q1143.644M / 145.832M--
Feb 27, 20242023/Q4164.314M / 155.031M--
Nov 8, 20232023/Q3153.880M / 143.387M--
Aug 8, 20232023/Q2135.563M / 143.658M--
May 9, 20232023/Q1153.764M / 139.023M--
--2022/Q4167.328M / 180.375M--
Nov 8, 20222022/Q3177.353M / 172.476M--
Aug 4, 20222022/Q2170.051M / 164.229M--

Unlock Free Earnings Estimates

Supernus Pharmaceuticals Earnings Reports

Read more

Analysis

Analyst Rating

Updated: May 15, 2024

Buy

  • Buy

    66.67%
  • Hold

    33.33%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg